Medical News Today: Common heartburn drugs tied to higher risk of death
A large study finds that PPIs - used by millions for heartburn and ulcers - are linked to higher risk of death and that the risk rises the longer the use. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 4, 2017 Category: Consumer Health News Tags: Acid Reflux / GERD Source Type: news

People taking heartburn drugs could have higher risk of death, study claims
Research suggests people on proton pump inhibitors are more likely to die than those taking different antacid or none at allMillions of people taking common heartburn andindigestion medications could be at an increased risk of death, research suggests.The drugs, known as proton pump inhibitors (PPIs), neutralise the acid in the stomach and are widely prescribed, with low doses also available without prescription from pharmacies. In the UK, doctors issue more than 50m prescriptions for PPIs every year.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 4, 2017 Category: Science Authors: James Rudd Tags: Drugs Health Science Society UK news Source Type: news

Proton pump inhibitors associated with raised mortality
Researchers suggest restricting indications for use of PPIs, and treatment duration Related items fromOnMedica Barrett ’s oesophagus (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 4, 2017 Category: UK Health Source Type: news

PPIs Linked With Higher Risk for Death PPIs Linked With Higher Risk for Death
Use and duration of proton-pump inhibitors should be limited to medical indications, researchers say. An expert agrees but says the excess risk is small and the drugs are still often the best option.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 3, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

PPIs Not Found to Raise Risk of Alzheimer ’ s Disease
New research debunks other studies suggesting that PPIs cause mental decline (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - June 29, 2017 Category: Psychiatry Tags: Family Medicine, Geriatrics, Gastroenterology, Internal Medicine, Neurology, Nursing, Pharmacy, Psychiatry, Journal, Source Type: news

Popular Heartburn Meds Don't Raise Alzheimer's Risk: Study
WEDNESDAY, June 28, 2017 -- Drugs used to treat acid reflux and ulcers don ' t appear to boost the risk of dementia, as has been previously suspected, new research suggests. The study focused on widely used proton pump inhibitors (PPIs) drugs --... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 28, 2017 Category: General Medicine Source Type: news

PPI-responsive Esophageal Eosinophilia: A Valid Diagnosis? PPI-responsive Esophageal Eosinophilia: A Valid Diagnosis?
Is proton pump inhibitor-responsive esophageal eosinophilia just an arbitrary construct, or does it have a distinct molecular and mechanistic basis? Explore the controversy in this article.Current Opinion in Gastroenterology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 28, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

PPIs Linked to Lower Cognitive Decline in Latest Study PPIs Linked to Lower Cognitive Decline in Latest Study
A new observational study has smoothed the waters somewhat over concerns about a possible increased risk for dementia with proton-pump inhibitors.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 22, 2017 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Proton pump inhibitors do not contribute to dementia or Alzheimer's disease
(American Geriatrics Society) Noting that the prescription of proton pump inhibitors is on the rise among middle-aged and older adults, a team of researchers designed a new study to examine PPIs and the risk of dementia, mild cognitive impairment, and Alzheimer's disease. They published their study in the Journal of the American Geriatrics Society. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 22, 2017 Category: International Medicine & Public Health Source Type: news

Your NEJM Group Today: Competency-Based Medical Education / PPIs & Kidney Disease? / Texas Primary Care Opportunities (FREE)
By the Editors Take a look at today ' s offering from NEJM Group:NEJM Knowledge+ Blog: What is … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 15, 2017 Category: Primary Care Source Type: news

Risk of aspirin-related bleeding is higher in the over-75s
Conclusion This valuable cohort study helps to quantify the extent of bleeding risk in people taking aspirin for secondary prevention of cardiovascular disease. Aspirin is well known to carry bleeding risk – particularly in older adults – but this study suggests the risk may be higher than previously thought. The researchers say that for adults under the age of 75, the annual bleeding risk at around 1% is similar to that suggested by previous trials, as is the ratio of bleeds to the number of cardiovascular events. However, this risk increases for older adults, especially for major bleeds of the stomach and upper diges...
Source: NHS News Feed - June 14, 2017 Category: Consumer Health News Tags: Medication Older people Source Type: news

Call to co-prescribe PPIs with daily aspirin for older patients
Long-term daily aspirin use is linked to a higher than expected risk of “disabling or fatal” bleeding in adults aged 75 or over, according to researchers in Oxford. (Source: Nursing Times)
Source: Nursing Times - June 14, 2017 Category: Nursing Source Type: news

Proposal: In the Elderly, Add PPIs to Aspirin for Secondary Prevention (FREE)
By Joe Elia Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Proton-pump inhibitors (PPIs) should be added when prescribing antiplatelet therapy after cardiovascular events in the elderly, researchers propose in The Lancet.The researchers followed over 3000 patients for … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 14, 2017 Category: Primary Care Source Type: news

Bleeding risk with long-term aspirin increases substantially with age
GPs should prescribe PPIs to elderly people to cut risk, researchers suggest Related items fromOnMedica Benefits of taking aspirin highest in women aged 65 plus Aspirin boosts cancer immunotherapy, study shows Long-term aspirin use linked to lower risk of gastrointestinal tract cancers Aspirin after mini-stroke reduces risk of major stroke (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 14, 2017 Category: UK Health Source Type: news

PPI Use and Risk of Hip Fracture in Kidney Transplants PPI Use and Risk of Hip Fracture in Kidney Transplants
PPIs are commonly prescribed for kidney transplant recipients -- but might their use be associated with an increased risk of hip fracture among these patients?American Journal of Kidney Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 1, 2017 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news